Skip to main content
Top
Published in: Cancer Causes & Control 2/2024

11-09-2023 | Breast Cancer | Original Paper

Socioeconomic and geographic disparities of breast cancer incidence according to stage at diagnosis in France

Authors: Claire Delacôte, Juan Manuel Ariza, Solenne Delacour-Billon, Stéphanie Ayrault-Piault, Giulio Borghi, Katia Menanteau, Aurélie Bouron, Magali Métais, Anne Cowppli-Bony, Florence Molinié

Published in: Cancer Causes & Control | Issue 2/2024

Login to get access

Abstract

Purpose

Low socioeconomic background (SB) has been associated with lower breast cancer (BC) incidence and higher BC mortality. One explanation of this paradox is the higher frequency of advanced BC observed in deprived women. However, it is still unclear if SB affects similarly BC incidence. This study investigated the link between SB and early/advanced BC incidence from Loire-Atlantique/Vendee Cancer registry data (France).

Materials and methods

Fourteen thousand three hundred fifty three women living in the geographic area covered by the registry and diagnosed with a primary BC in 2008–2015 were included. SB was approached by a combination of two ecological indexes (French European Deprivation Index and urban/rural residence place). Mixed effects logistic and Poisson regressions were used, respectively, to estimate the odds of advanced (stage ≥ II) BC and the ratio of incidence rates of early (stage 0–I) and advanced BC according to SB, overall and by age group (< 50, 50–74, ≥ 75).

Results

Compared to women living in affluent-urban areas, women living in deprived-urban and deprived-rural areas had a higher proportion of advanced BC [respectively, OR = 1.11 (1.01–1.22), OR = 1.60 (1.25–2.06)] and lower overall (from − 6 to − 15%) and early (from − 9 to − 31%) BC incidences rates Advanced BC incidence rates were not influenced by SB. These patterns were similar in women under 75 years, especially in women living in deprived-rural areas. In the elderly, no association between SB and BC frequency/incidence rates by stage was found.

Conclusion

Although advanced BC was more frequent in women living in deprived and rural areas, SB did not influence advanced BC incidence. Therefore, differences observed in overall BC incidence according to SB were only due to higher incidence of early BC in affluent and urban areas. Future research should confirm these results in other French areas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stratégie décennale de lutte contre les cancers 2021–2030 [in French] Stratégie décennale de lutte contre les cancers 2021–2030 [in French]
2.
go back to reference Touraine M (2014) Plan cancer 2014–2019: Guérir et prévenir les cancers: donnons les mêmes chances à tous, partout en France. Ministère des affaires sociales et de la santé, Paris Touraine M (2014) Plan cancer 2014–2019: Guérir et prévenir les cancers: donnons les mêmes chances à tous, partout en France. Ministère des affaires sociales et de la santé, Paris
4.
go back to reference Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Remontet L, Colonna M, Dantony E, Delafosse P, Molinié F, Woronoff AS, Bouvier AM, Bossard N, Monnereau A (2019) Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Étude à partir des registres des cancers du réseau Francim. Résultats préliminaires. Rapport. Santé Publique France, Saint-Maurice (Fra) Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Remontet L, Colonna M, Dantony E, Delafosse P, Molinié F, Woronoff AS, Bouvier AM, Bossard N, Monnereau A (2019) Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Étude à partir des registres des cancers du réseau Francim. Résultats préliminaires. Rapport. Santé Publique France, Saint-Maurice (Fra)
22.
go back to reference Sobin LH, Gosporadowicz MK, Wittelkind C (2011) TNM classification of malignant tumors, 7th edn. Wiley, Hoboken Sobin LH, Gosporadowicz MK, Wittelkind C (2011) TNM classification of malignant tumors, 7th edn. Wiley, Hoboken
24.
go back to reference Guillaume E, Pornet C, Dejardin O, Launay L, Lillini R, Vercelli M, Marí-Dell’Olmo M, Fernández Fontelo A, Borrell C, Ribeiro AI, de Pina MF, Mayer A, Delpierre C, Rachet B, Launoy G (2016) Development of a cross-cultural deprivation index in five European countries. J Epidemiol Community Health 70:493–499. https://doi.org/10.1136/jech-2015-205729CrossRefPubMed Guillaume E, Pornet C, Dejardin O, Launay L, Lillini R, Vercelli M, Marí-Dell’Olmo M, Fernández Fontelo A, Borrell C, Ribeiro AI, de Pina MF, Mayer A, Delpierre C, Rachet B, Launoy G (2016) Development of a cross-cultural deprivation index in five European countries. J Epidemiol Community Health 70:493–499. https://​doi.​org/​10.​1136/​jech-2015-205729CrossRefPubMed
33.
go back to reference Menvielle G, Kunst AE, van Gils CH, Peeters PH, Boshuizen H, Overvad K, Olsen A, Tjonneland A, Hermann S, Kaaks R, Bergmann MM, Illner A-K, Lagiou P, Trichopoulos D, Trichopoulou A, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, May A, Monninkhof E, Braaten T, Lund E, Quirós JR, Duell EJ, Sánchez MJ, Navarro C, Ardanaz E, Borgquist S, Manjer J, Khaw KT, Allen NE, Reeves GK, Chajes V, Rinaldi S, Slimani N, Gallo V, Vineis P, Riboli E, Bueno-de-Mesquita HB (2011) The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition. Am J Epidemiol 173:26–37. https://doi.org/10.1093/aje/kwq319CrossRefPubMed Menvielle G, Kunst AE, van Gils CH, Peeters PH, Boshuizen H, Overvad K, Olsen A, Tjonneland A, Hermann S, Kaaks R, Bergmann MM, Illner A-K, Lagiou P, Trichopoulos D, Trichopoulou A, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, May A, Monninkhof E, Braaten T, Lund E, Quirós JR, Duell EJ, Sánchez MJ, Navarro C, Ardanaz E, Borgquist S, Manjer J, Khaw KT, Allen NE, Reeves GK, Chajes V, Rinaldi S, Slimani N, Gallo V, Vineis P, Riboli E, Bueno-de-Mesquita HB (2011) The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition. Am J Epidemiol 173:26–37. https://​doi.​org/​10.​1093/​aje/​kwq319CrossRefPubMed
38.
go back to reference Lamy S, Molinié F, Daubisse-Marliac L, Cowppli-Bony A, Ayrault-Piault S, Fournier E, Woronoff AS, Delpierre C, Grosclaude P (2019) Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example. BMC Public Health 19:857. https://doi.org/10.1186/s12889-019-7220-4CrossRefPubMedPubMedCentral Lamy S, Molinié F, Daubisse-Marliac L, Cowppli-Bony A, Ayrault-Piault S, Fournier E, Woronoff AS, Delpierre C, Grosclaude P (2019) Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example. BMC Public Health 19:857. https://​doi.​org/​10.​1186/​s12889-019-7220-4CrossRefPubMedPubMedCentral
Metadata
Title
Socioeconomic and geographic disparities of breast cancer incidence according to stage at diagnosis in France
Authors
Claire Delacôte
Juan Manuel Ariza
Solenne Delacour-Billon
Stéphanie Ayrault-Piault
Giulio Borghi
Katia Menanteau
Aurélie Bouron
Magali Métais
Anne Cowppli-Bony
Florence Molinié
Publication date
11-09-2023
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2024
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01779-8

Other articles of this Issue 2/2024

Cancer Causes & Control 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine